CDKN2A exon 1B deletion predisposing to melanoma and neural system tumour syndrome

Clin Exp Dermatol. 2022 Dec;47(12):2284-2285. doi: 10.1111/ced.15354. Epub 2022 Oct 25.

Abstract

CDKN2A at chromosome positon 9p21 is a tumour suppressor gene encoding the cell cycle regulators p16 and p14ARF. While melanoma is associated with variants affecting both transcripts, families with mutations involving the p14ARF-specific exon 1B may be predisposed to central nervous system tumours. We describe a family with a deletion of exon 1B in CDKN2A, who had multiple cutaneous melanomas, neural tumours and various malignancies.

Publication types

  • Letter

MeSH terms

  • Cyclin-Dependent Kinase Inhibitor p16 / genetics
  • Exons / genetics
  • Humans
  • Melanoma* / genetics
  • Pedigree
  • Tumor Suppressor Protein p14ARF* / genetics

Substances

  • Tumor Suppressor Protein p14ARF
  • Cyclin-Dependent Kinase Inhibitor p16
  • CDKN2A protein, human

Supplementary concepts

  • Melanoma astrocytoma syndrome